Clinical Effectiveness Of Omalizumab In Severe Allergic Asthma Above The Recommended Dosing Range: The Australian Xolair Registry

Citation

Hew, M, Gillman, A, Sutherland, M et al 2016, 'Clinical Effectiveness Of Omalizumab In Severe Allergic Asthma Above The Recommended Dosing Range: The Australian Xolair Registry', International Conference of the American-Thoracic-Society (ATS), American Thoracic Society, United States, pp. A1407.

Year

2016

Fields of Research

  • Respiratory Diseases
  • Allergy

Updated:  03 March 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers